Cargando…

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

BACKGROUND: Interleukin 1 (IL-1) is implicated in neuroinflammation, an essential component of neurodegeneration. We evaluated the potential anti-inflammatory effect of a novel peptide antagonist of IL-1 signaling, Ilantide. METHODS: We investigated the binding of Ilantide to IL-1 receptor type I (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klementiev, Boris, Li, Shizhong, Korshunova, Irina, Dmytriyeva, Oksana, Pankratova, Stanislava, Walmod, Peter S, Kjær, Laura K, Dahllöf, Mattias S, Lundh, Morten, Christensen, Dan P, Mandrup-Poulsen, Thomas, Bock, Elisabeth, Berezin, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923439/ https://www.ncbi.nlm.nih.gov/pubmed/24490798 http://dx.doi.org/10.1186/1742-2094-11-27

Ejemplares similares

Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects
por: Dmytriyeva, Oksana, et al.
Publicado: (2016)

Artemin and an Artemin-Derived Peptide, Artefin, Induce Neuronal Survival, and Differentiation Through Ret and NCAM
por: Ilieva, Mirolyuba, et al.
Publicado: (2019)

Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
por: Dahlby, Tina, et al.
Publicado: (2020)

The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival
por: Pankratova, Stanislava, et al.
Publicado: (2018)

Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
por: Gotfryd, Kamil, et al.
Publicado: (2010)

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
por: Larsen, Claus M., et al.
Publicado: (2009)

Neuritogenic and Neuroprotective Properties of Peptide Agonists of the Fibroblast Growth Factor Receptor
por: Li, Shizhong, et al.
Publicado: (2010)

Modeling the early stages of Alzheimer’s disease by administering intracerebroventricular injections of human native Aβ oligomers to rats
por: Baerends, Eva, et al.
Publicado: (2022)

A Peptide Antagonist of the ErbB1 Receptor Inhibits Receptor Activation, Tumor Cell Growth and Migration In Vitro and Xenograft Tumor Growth In Vivo
por: Xu, Ruodan, et al.
Publicado: (2010)

A Systematic Comparison of Purification and Normalization Protocols for Quantitative MicroRNA Expressional Profiling in Insulin-Producing Cells
por: Vestergaard, Anna Lindeløv, et al.
Publicado: (2016)

Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients
por: Jensen, Thorbjørn Søren Rønn, et al.
Publicado: (2018)

JNK1 Protects against Glucolipotoxicity-Mediated Beta-Cell Apoptosis
por: Prause, Michala, et al.
Publicado: (2014)

A neuroligin-1-derived peptide stimulates phosphorylation of the NMDA receptor NR1 subunit and rescues MK-801-induced decrease in long-term potentiation and memory impairment
por: Korshunova, Irina, et al.
Publicado: (2015)

Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia
por: Mahmood, Badar, et al.
Publicado: (2016)

Interleukin Expression after Injury and the Effects of Interleukin-1 Receptor Antagonist
por: Chamberlain, Connie S., et al.
Publicado: (2013)

Pharmacology of Cell Adhesion Molecules of the Nervous System
por: Kiryushko, Darya, et al.
Publicado: (2007)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
por: Abadie, Bryan Q., et al.
Publicado: (2022)

JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression
por: Prause, Michala, et al.
Publicado: (2016)

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
por: Bjrök, P., et al.
Publicado: (1992)

Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria
por: Machura, E., et al.
Publicado: (2013)

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)
por: Maslennikov, Roman, et al.
Publicado: (2021)

Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: Evidence of Improved Immune Regulation
por: Ablamunits, Vitaly, et al.
Publicado: (2012)

The Connexin 43 Regulator Rotigaptide Reduces Cytokine-Induced Cell Death in Human Islets
por: Ghiasi, Seyed Mojtaba, et al.
Publicado: (2020)

Role of interleukin-25 in development of spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice
por: Abe, Yasuharu, et al.
Publicado: (2017)

Cytokines and Type 1 Diabetes: A Numbers Game
por: Grunnet, Lars Groth, et al.
Publicado: (2011)

Proteins Involved in Synaptic Plasticity Are Downregulated in the Cerebrospinal Fluid of Infants With Clinical Sepsis Complicated by Neuroinflammation
por: Jiang, Ping-Ping, et al.
Publicado: (2022)

NAMPT-mediated NAD(+) biosynthesis is indispensable for adipose tissue plasticity and development of obesity
por: Nielsen, Karen Nørgaard, et al.
Publicado: (2018)

Mutual stimulatory signaling between human myogenic cells and rat cerebellar neurons
por: Tamáš, Michal, et al.
Publicado: (2021)

Production of interleukin-1 receptor antagonist by human articular chondrocytes
por: Palmer, Gaby, et al.
Publicado: (2002)

Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
por: Vecile, Elena, et al.
Publicado: (2013)

Interleukin-1 Receptor Antagonist Isoforms in Collagen-Induced Arthritis
por: Gabay, Cem, et al.
Publicado: (2000)

Interleukin receptor antagonist induction in kidney transplantation: Is it worth the price?
por: Kher, V.
Publicado: (2013)

Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
por: Gong, Zhenqiang, et al.
Publicado: (2018)

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
por: Fan, Yu-Ching, et al.
Publicado: (2020)

Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
por: Lindblad, Caroline, et al.
Publicado: (2023)

Developing Interpersonal Trust Between Service Users and Professionals in Integrated Services: Compensating for Latent Distrust, Vulnerabilities and Uncertainty Shaped by Organisational Context
por: Poulsen, Rie Mandrup, et al.
Publicado: (2021)

Interleukin 1-β, interleukin-1 receptor antagonist and vitamin D levels in children with atopic dermatitis
por: Machura, Edyta, et al.
Publicado: (2018)

Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia
por: Kleberg, Karen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pq9vg77s2nm457mm616tpi464v